PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists move closer to developing 'game-changing' test to diagnose Parkinson's

2021-03-11
(Press-News.org) Results published today show it is possible to identify Parkinson's based on compounds found on the surface of skin. The findings offer hope that a pioneering new test could be developed to diagnose the degenerative condition through a simple and painless skin swab.

Scientists at The University of Manchester have developed a technique which works by analysing compounds found in sebum - the oily substance that coats and protects the skin - and identifying changes in people with Parkinson's Disease. Sebum is rich in lipid-like molecules and is one of the lesser studied biological fluids in the diagnosis of the condition. People with Parkinson's may produce more sebum than normal - a condition known as seborrhoea.

The research has been funded by charities Parkinson's UK and the Michael J. Fox Foundation as well as The University of Manchester Innovation Factory. The work was originally funded following an observation by Joy Milne, whose husband was diagnosed with Parkinson's at the age of 45. Working with Dr Tilo Kunath at the University of Edinburgh, Joy demonstrated an incredible ability to distinguish a distinctive Parkinson's odour in individuals using her sense of smell, even before symptoms emerge in those affected.

The team, led by Professor Perdita Barran, The University of Manchester, and the clinical lead Professor Monty Silverdale at Salford Royal Foundation Trust, recruited 500 people with and without Parkinson's. Samples of sebum were taken from their upper backs for analysis. Using different mass spectrometry methods, 10 chemical compounds in sebum were identified which are elevated or reduced in people with Parkinson's. This allows scientists to distinguish people with Parkinson's with 85 per cent accuracy.

The team confirmed their earlier findings published in ACS Central Science that the volatile compounds on skin can be used to diagnose the condition, increasing the number of people sampled and including participants from the Netherlands, as well as the UK.

In a new study published today in Nature Communications, high resolution mass spectrometry was used to profile the complex chemical signature in sebum of people with Parkinson's and show subtle but fundamental changes as the condition progresses. Detailed analysis showed changes in people with Parkinson's in lipid (fat) processing and mitochondria. Problems with mitochondria - the tiny energy-producing batteries that power cells - are one of the hallmarks of Parkinson's.

This means this 'world first' testing strategy is not only useful in diagnosing Parkinson's but also in monitoring the development of the condition. The skin swab could provide an incredibly important new tool in clinical trials helping researchers measure whether new, experimental treatments are able to slow, stop or reverse the progression of Parkinson's.

The study unveiled novel diagnostic sebum-based biomarkers for Parkinson's, provides insight into understanding of how the condition develops, and links lipid dysregulation to altered mitochondrial function.

These promising results published today could lead to a definitive test to diagnose Parkinson's accurately, speedily and cost effectively. The team is now seeking funding to further develop the test and explore the potential for using the test to 'stratify' patients.

Working with the University of Manchester Innovation Factory, the team has patents filed for their diagnostic techniques and are planning to create a spin-out company to commercialise the new tests. They are also working to use this approach to develop tests for COVID-19 as shown in research last week in EClinical Medicine as well as other conditions and are actively seeking investors interested in supporting the drive to bring this technology to market.

Professor Perdita Barran, Professor of Mass Spectrometry at The University of Manchester, said: "We believe that our results are an extremely encouraging step towards tests that could be used to help diagnose and monitor Parkinson's. "Not only is the test quick, simple and painless but it should also be extremely cost-effective because it uses existing technology that is already widely available. "We are now looking to take our findings forwards to refine the test to improve accuracy even further and to take steps towards making this a test that can be used in the NHS and to develop more precise diagnostics and better treatment for this debilitating condition."

Parkinson's tends to develop gradually and it may be many months, even years, before the symptoms become obvious enough for an individual to visit their GP. A DaTscan is regularly used to help specialists confirm the loss of dopamine-producing cells that cause the development of Parkinson's. However, similar loss may also occur in some other rarer neurological conditions. With no molecular test for the condition, diagnosis is made by a neurologist based on a combination of symptoms such as tremor, slowness, stiffness and balance issues. However, many of the symptoms of Parkinson's can overlap with other conditions, especially in the early stages when progression is gradual and symptoms are more subtle.

In a recent survey of more than 2,000 people with Parkinson's carried out by Parkinson's UK, more than a quarter (26 per cent) reported they were misdiagnosed with a different condition before receiving the correct Parkinson's diagnosis.¹

Professor David Dexter, Associate Director of Research at Parkinson's UK, said: "We are proud to have part-funded this groundbreaking research which marks a significant step towards developing a quick and accurate test that can not only revolutionise the way we diagnose Parkinson's, but also allow us to monitor how this debilitating condition progresses. "Every hour, two more people in the UK are diagnosed with Parkinson's and a significant portion of these people may well have been misdiagnosed with, and treated for, another condition before receiving their correct diagnosis. This has been compounded in the COVID-19 pandemic where people have been left waiting and have faced months of anxiety to confirm their diagnosis by a health professional. However, with this innovative test, we could see people being diagnosed quickly and accurately enabling them to access vital treatment and support to manage their Parkinson's symptoms sooner."

56-year-old Daxa Kalayci lives in Leicester and was diagnosed with Parkinson's in September 2019. She was misdiagnosed several times over four years before finally finding out she had the condition.

"I was misdiagnosed with anxiety, stress-related tremors and told that my problems stemmed from going through the menopause. I embarked on a 4-month cruise across the globe not knowing I had Parkinson's. Just two weeks into the trip, my symptoms worsened and my dream holiday turned into a nightmare. Without confirmation that it was Parkinson's, which I had suspected for a long time, I was left with unpleasant side-effects caused by different medications prescribed to manage my symptoms.

"Despite my diagnosis eventually being confirmed by a DaTscan, a quick and simple diagnostic test for Parkinson's would have given me the chance to start my treatment earlier and enjoy life a lot more. But instead, I lost so many years not being able to pursue a career as a paramedic or go back to Nursing.

"This test could be a game-changer for people living with Parkinson's and searching for answers like I was. I am so happy with this news because it will mean that in future people won't have to experience the anxiety of multiple appointments, long waiting times and sleepless nights. The sooner this test is available, the better. Anything that can help people looking for a diagnosis is a bonus."

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Lehigh U. researchers: 'One step closer to unlocking mysteries of the bio/nano interface'

Lehigh U. researchers: One step closer to unlocking mysteries of the bio/nano interface
2021-03-11
An interdisciplinary research team at Lehigh University has unraveled how functional biomaterials rely upon an interfacial protein layer to transmit signals to living cells concerning their adhesion, proliferation and overall development. According to an article published today in Scientific Reports, the nanoscale features and properties of an underlying substrate do not impact the biological response of cells directly. However, these properties indirectly influence cell behavior through their control over adsorbed proteins. In the article, "Nanostructure ...

Firefly tourism takes flight, sparking wonder and concern

Firefly tourism takes flight, sparking wonder and concern
2021-03-11
Firefly beetles rank among the world's most charismatic creatures, with luminous courtship displays that have now turned them into a popular attraction for wildlife tourists. In the first comprehensive review of firefly tourism, published in the journal Conservation Science and Practice, an international team of biologists led by a Tufts University researcher, reveal that an estimated 1 million people now travel each year to witness bioluminescent performances starring some two dozen firefly species around the world. But the authors also point out that while this unique, insect-based tourism ...

Mindfulness meditation improves quality of life in heart attack survivors

2021-03-11
An eight-week programme of mindfulness meditation improves quality of life and reduces fear of activity in heart attack patients, according to research presented today at ESC Acute CardioVascular Care 2021, an online scientific congress of the European Society of Cardiology (ESC).1 "A heart attack is a serious life-threatening event and survivors can suffer from low quality of life," said study author Dr. Canan Karadas of Hacettepe University, Ankara, Turkey. "One reason is a fear of movement, called kinesiophobia, which limits daily activity due to concerns of another heart attack." "Mindfulness refers to the mental state achieved by focusing awareness on the present moment, ...

Scientists found new way to synthesize chiral tetraarylmethanes

Scientists found new way to synthesize chiral tetraarylmethanes
2021-03-11
The research was published on the journal Nature Catalysis on December 14, 2020. A strong bias towards linear and disc-shaped molecules has long been observed in drug molecules. In contrast, spherical molecules have been utilized on far fewer occasions, due to the lack of efficient access to the latter chemical space. Specifically, efficient strategies to synthesize tetraarylmethanes, a unique family of spherical molecules, have remained scarce. Chiral tetraarylmethanes (CTAMs), a unique family of spherical molecules which bear four different aryl groups with defined stereochemistry, remain as a mystery due to the lack of efficient asymmetric synthesis. The challenge in asymmetric synthesis of CTAMs lies in not only the high barrier in making ...

Elite philanthropy does little to solve problems caused by rising social inequalities

2021-03-11
Giving at scale by the super-wealthy has done little to redistribute wealth from rich to poor, helping perpetuate social inequalities rather than remedying them, while paying considerable dividends to donors in the form of privilege and influence in society and politics, new research shows. In the research paper 'Elite philanthropy in the United States and the United Kingdom in the new age of inequalities' researchers at the University of Bath School of Management and Newcastle University Business School also conclude that giving by the super-wealthy has failed significantly to benefit poor countries in the developing ...

COVID-19 risks to pregnant women and their babies outlined in global research review

2021-03-11
Pregnant women remain at increased risk of severe COVID-19, and their risk of being admitted to intensive care or needing invasive ventilation is higher than non-pregnant reproductive aged women with the virus, an ongoing global study has found. Pregnant women with COVID-19 are at increased risk of severe COVID-19, particularly if they are from ethnic minority backgrounds, or if they have pre-existing conditions like obesity, high blood pressure and diabetes, concludes the research led by the University of Birmingham and World Health Organization (WHO). Their research, ...

Lockdowns linked to rise in eating disorder symptoms

2021-03-11
New research indicates that lockdowns to help tackle the spread of COVID-19 could be linked to an increase in symptoms associated with eating disorders. The longitudinal study, carried out by academics from Anglia Ruskin University (ARU) in Cambridge, England, and published in the journal Psychiatry Research, examined the behaviour and attitudes of 319 health club members during the summer of 2020. The researchers followed up initial research into addictive or unhealthy behaviours, conducted in 2019, to investigate the effects of the first COVID-19 restrictions introduced in the spring of 2020. Participants, with an average age of 37, completed the eating attitudes test, called EAT-26, which involved answering questions related to statements ...

Dog's body size and shape could indicate a greater bone tumour risk

Dogs body size and shape could indicate a greater bone tumour risk
2021-03-11
Osteosarcoma is a painful and aggressive bone tumour in dogs that is known to be more common in certain breeds than others. New research has now confirmed that larger breeds, such as Rottweiler, Great Dane and Rhodesian Ridgeback, have a greater risk of osteosarcoma than smaller breeds, as well as showing that breeds with shorter skulls and legs have lower osteosarcoma risk. The findings could inform future breed health reforms as well as studies into the way tumours develop from normal bone. The study led by the University of Bristol Veterinary School in collaboration with Cardiff University and Royal Veterinary College (RVC) London, and using data from VetCompass™ and Veterinary Pathology Group (VPG) histology, looked at the epidemiology surrounding which dog breeds ...

Elite women might have ruled El Argar 4,000 years ago

2021-03-11
Women of the ruling class may have played an important role in the governance of El Argar, a society which flourished in the southeast of the Iberian Peninsula between 2200 and 1550 BCE, and which in the last two centuries of its existence, developed into the first state organisation of the western Mediterranean. These are the conclusions reached by researchers from the Universitat Autònoma de Barcelona (UAB) who led a study analysing the contents of a princely tomb (Grave 38), containing two individuals and a large amount of valuable items. The tomb was discovered in 2014 at the archaeological site of La Almoloya in Pliego, Murcia, beneath what was later identified to be the governing hall of a palatial building. "La Almoloya ...

High rates of mental health disorder among all health and social care groups

2021-03-11
Almost 60% of frontline health and social care workers (HSCWs) experienced a mental health disorder during the first COVID-19 lockdown, with many suffering "very high rates of distress", suggests a new study led by researchers at UCL and the University of Haifa, Israel. Given the significantly high levels of mental health disorders across all HSCWs, the researchers (part of the UCL-led COVID Trauma Response Working Group*), are now calling for long-term planning to meet the needs of staff from across health and social care, including specialist trauma services to be set up for healthcare workers, similar to the specialist commissioned NHS psychological trauma services for military veterans. The 'Frontline-COVID study', published ...

LAST 30 PRESS RELEASES:

Genetic causes of cerebral palsy uncovered through whole-genome sequencing

Modesty and boastfulness – perception depends on usual performance

Do sweeteners increase your appetite? New evidence from randomised controlled trial says no 

Women with obesity do not need to gain weight during pregnancy, new study suggests

Individuals with multiple sclerosis face substantially greater risk of hospitalisation and death from COVID-19, despite high rates of vaccination

Study shows obesity in childhood associated with a more than doubling of risk of developing multiple sclerosis in early adulthood

Rice Emerging Scholars Program receives $2.5M NSF grant to boost STEM education

Virtual rehabilitation provides benefits for stroke recovery

Generative AI develops potential new drugs for antibiotic-resistant bacteria

Biofuels could help island nations survive a global catastrophe, study suggests

NJIT research team discovering how fluids behave in nanopores with NSF grant

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

Social media use may help to empower plastic surgery patients

Q&A: How to train AI when you don't have enough data

Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities

Discovering Van Gogh in the wild: scientists unveil a new gecko species

Small birds spice up the already diverse diet of spotted hyenas in Namibia

Imaging detects transient “hypoxic pockets” in the mouse brain

Dissolved organic matter could be used to track and improve the health of freshwaters

Indoor air quality standards in public buildings would boost health and economy, say international experts

Positive associations between premenstrual disorders and perinatal depression

New imaging method illuminates oxygen's journey in the brain

Researchers discover key gene for toxic alkaloid in barley

New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects

Bidirectional link between premenstrual disorders and perinatal depression

Cell division quality control ‘stopwatch’ uncovered

Vaccine protects cattle from bovine tuberculosis, may eliminate disease

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

[Press-News.org] Scientists move closer to developing 'game-changing' test to diagnose Parkinson's